【QIAseq パネル活用事例がここに】 海外研究者によるクリニカルシークエンスの実際
分子バーコード搭載でカバレッジが最大化されるユニークなプライマーデザインのQIAseq Targeted DNA Panels パネル。そして、DNA 変異、融合遺伝子、遺伝子発現解析のターゲット解析が同一サンプルから可能なパネルQIAseq Multimodal Panels における活用事例により、新たな知見をお届けします。

以下5つのオンデマンドウェビナー(英語)をご用意しております。
【ウェビナー1】Evaluation of QIAseq Multimodal Panel in comprehensive genomic profiling (CGP) (59:51)
演者:Dr. Ravindra Kolhe
(Vice Chair, Pathology, Medical College of Georgia at Augusta University)
内容:The insight on using the QIAseq Pan-cancer Multimodal Panel for comprehensive genomic profiling is to streamline the analysis of cancer-associated alternations by using a single workflow to achieve high operational efficiency.

【ウェビナー2】QIAseq Multimodal Panels for lung cancer profiling (47:24)
演者:Dr. Sylvia Herold
(Institut für Pathologie, Universitätsklinikum Dresden)
内容:How her team has streamlined the profiling of lung cancer-associated alterations by using the QIAseq Lung Multimodal Panel

【ウェビナー3】Validating a targeted NGS approach for glioma characterization (55:50)
演者:Dr. Michela Bulfoni
(Institute of Surgical Pathology, Istituto di Anatomia Patologica, University of Udine)
内容:To validate a targeted NGS approach for molecular characterization of glioblastoma and stem cells isolated in four molecular subclasses.

【ウェビナー4】Tumor profiling by NGS: Challenges of integrating genomic testing into clinical pathways (61:07)
演者:Dr. Pauline Rehal
(Principal Clinical Scientist, West Midlands Regional Genetics Laboratory)
内容:The challenges of the increasing complexity of biomarker testing needs and the hurdles labs will encounter when implementing NGS for precision oncology testing.

【ウェビナー5】Identification of genetic mutations in HR deficient cancers using QIAseq HRD panel (56:45)
演者:Dr. Nils Hartmann
(Molecular Pathology, Head of NGS, Institute for Pathology, Mainz University Medical Center)
内容:How his lab used a streamlined sample to sequencing workflow to identify genetic mutations in HR deficient breast, ovarian and prostate cancer.

【お問い合わせ先】info-jp@qiagen.com

>>詳細はこちら